Amgen/Enzon G-CSF collaboration
Executive Summary
Will focus on the development of a longer-acting formulation of Amgen's neutrophil stimulant Neupogen using Enzon's proprietary Pegnology polyethylene glycol remodeling technology. In addition, Amgen has an exclusive option to collaborate with Enzon in the development of certain other therapeutic PEG compounds.